Overview
Hirohito Tada practices in Suita, Japan. Tada is highly rated in 4 conditions, according to our data. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Lymphadenectomy.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung Cancer
- Lung CancerTada isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Experienced
- Breast CancerTada isExperienced. Learn about Breast Cancer.
- EmpyemaTada isExperienced. Learn about Empyema.
- HER-2 Positive Breast Cancer
- LymphadenectomyTada isExperienced. Learn about Lymphadenectomy.
- Neuroendocrine TumorTada isExperienced. Learn about Neuroendocrine Tumor.
- Pulmonary FibrosisTada isExperienced. Learn about Pulmonary Fibrosis.